Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients
The Angioedema Activity Score (AAS) is recommended by the EAACI/GA2LEN/EDF/WAO guidelines for urticaria as the standard measure for assessing disease activity in patients with recurrent angioedema (RAE). To date, it has been translated into 80 languages for use in 52 countries, but it has not been f...
Main Authors: | Kanokvalai Kulthanan, Leena Chularojanamontri, Chuda Rujitharanawong, Puncharas Weerasubpong, Karsten Weller, Marcus Maurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/9157895 |
Similar Items
-
Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change
by: Kanokvalai Kulthanan, et al.
Published: (2019-10-01) -
Cholinergic Urticaria: Clinical Presentation and Natural History in a Tropical Country
by: Chuda Rujitharanawong, et al.
Published: (2020-01-01) -
Angioedema: Clinical and Etiological Aspects
by: Kanokvalai Kulthanan, et al.
Published: (2007-01-01) -
Positive Yield of Autologous Plasma Skin Testing among Thai Patients with Urticaria and Angioedema due to Non-steroidal Anti-inflammatory Drugs
by: Kanokvalai Kulthanan, et al.
Published: (2014-01-01) -
A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL)
by: Satoshi Morioke, et al.
Published: (2021-10-01)